Abstract

The complement system is a group of soluble and membrane-bound proteins belonging to the innate arm of the immune system, offering protection against intruders, including drug delivery systems, as well as regulating host homeostasis. However, when uncontrolled, complement activation could trigger inflammatory reactions. Considering these, careful assessment of complement activation by particulate medicines becomes important, since over activation of the complement system could negatively impact their therapeutic potential. For careful complement analysis, meticulous handling and characterisation of sera/plasma is needed but regularly omitted by the research community. Here, we draw attention to this problem and call for implementation of quality assessment guidelines in sera/plasma preparation, storage and validation. We further highlight critical and variable biological factors that affect complement evaluation. These measure are necessary for reproducible complement mapping and for eliminating erroneous conclusions on complement evasion/activation properties of investigational and regulatory-approved particulate medicines.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.